Impact of amyloid PET in the clinical care of veterans in a tertiary memory disorders clinic
Open Access
- 17 August 2022
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Vol. 8 (1) , e12320
Abstract
Introduction: We aimed to characterize the clinical impact of amyloid PET (APET) in a veteran population with cognitive decline by comparing differences in management between those who did and did not have an APET. Methods: This was a retrospective observational study. Poisson regressions and logistic regression were used for comparisons. Results: Out of 565 veterans, 197 underwent APET; positivity rate was 36.55%. Having an APET was associated with longer follow‐up, and increased diagnostic variability; it was not associated with number of additional studies, cholinesterase inhibitors prescription, or referrals to research. A positive APET was associated with less diagnostic variability, fewer additional tests, greater cholinesterase inhibitor prescriptions, and more research referrals. Discussion: In a medically complex, real‐world population, APET yielded lower positivity rates and was not associated with classical clinical utility variables when comparing patients with and without an APET. APET may be used more to “rule out” rather than to confirm Alzheimer's disease. Highlights: Amyloid PET was associated with longer follow‐up, and higher diagnostic variability. No association was seen with cholinesterase inhibitors prescription, or referrals to research. In complex patients, expected amyloid PET positivity rates are lower than previously described. Amyloid PETs were used to “rule out” AD than to confirm the diagnosis of AD.Keywords
This publication has 27 references indexed in Scilit:
- Are common mental disorders more prevalent in the UK serving military compared to the general working population?Psychological Medicine, 2015
- The mental health of the UK Armed Forces: where facts meet fictionEuropean Journal of Psychotraumatology, 2014
- Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationAlzheimer's & Dementia, 2013
- Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive DeclineAlzheimer Disease & Associated Disorders, 2013
- Impact of molecular imaging on the diagnostic process in a memory clinicAlzheimer's & Dementia, 2012
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010Journal of Neuropathology & Experimental Neurology, 2012
- Clinical Criteria for the Diagnosis of Alzheimer Disease: Still Good After All These YearsThe American Journal of Geriatric Psychiatry, 2008
- Development and validation of the Geriatric Anxiety InventoryInternational Psychogeriatrics, 2007
- Prevalence of Dementia among Veterans Affairs Medical Care System UsersDementia and Geriatric Cognitive Disorders, 2005
- Trail Making Test A and B: Normative data stratified by age and educationArchives of Clinical Neuropsychology, 2004